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Objective: accelerated re-endothelialisation may inhibit the development of restenosis. Basic Fibroblast Growth Factor
(bFGF) plays a key role for early proliferative activity in the artery following injury. Therefore, this study was devised to
examine the effect of photodynamic therapy (PDT) on post-injury re-endothelialisation in vivo, and bFGF-mRNA
expression in endothelial cells (EC) in vitro.
Materials and methods: rat carotid arteries were balloon-injured prior to PDT. Arteries were analysed after 1, 3, 5, 14
and 30 days. Morphometric measurements were undertaken following injection of 0.5% Evans Blue which stains
non-endothelialised surfaces only. To identify EC, immunohistochemistry (CD-31) was performed. Proliferation was
assessed by fluorescence cell counting. PCR quantification of bFGF-mRNA expression and proliferation were assessed in
bovine aortic EC which were plated on isolated, PDT-treated EC-derived extracellular matrix at (12), 24, 48 (72 h).
Results: three days following PDT, arteries displayed significantly increased endothelial lining (p 0.02), which was more
pronounced at 5 (p 0.03) and 14 days (p 0.02). At 30 days no relevant differences between PDT and control were noted.
EC proliferation on PDT-treated matrix was significantly increased at 24, 48, and 72 h (p 0.0004), whereas bFGF-mRNA
expression was significantly increased at 24 h only (p 0.007).
Conclusion: post-injury PDT appears to accelerate re-endothelialisation. Expression of bFGF-mRNA, however, although
increased shortly after PDT, may not be responsible for a constant stimulation of EC proliferation.
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Multiple strategies have been employed clinically and
experimentally to inhibit postinterventional vascular
restenosis, by interfering with growth factors believed
to contribute directly to the development of intimal
hyperplasia (IH).1 Three phases in the development of
IH have been categorised in the rat balloon-injury
model.2 A hyper-acute, an acute and a chronic stage.
One of the most potent cellular and particularly
matrix resident growth factors, bFGF (basic Fibroblast
Growth Factor), is induced and up-regulated within
12 h after injury. bFGF has been implicated in regulat-
ing autocrine, and possibly intracrine endothelial cell
activity.3,4 Subconfluent, migrating endothelial cells
are known to express elevated levels of endogenousPlease address all correspondence to: F. Adili, Theodor-Stern-Kai 7,
D-60590 Frankfurt, Germany.
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1078±5884/02/020166 10 $35.00/0 # 2002 Elsevier Science Ltd. AlbFGF in vitro5 and in vivo.6 It induces EC (Endothelial
cells) migration and proliferation in vitro and stimu-
lates angiogenesis and re-endothelialisation in vivo.
Moreover, bFGF regulates the expression of a number
of EC genes, such as monocyte chemoattractant pro-
tein-1 (MCP-1), molecules of the proteolytic balance
(plasminogen activator (tPA and uPA), plasminogen
activator inhibitor-1), adhesion molecules (ICAM-1,
integrins) and extracellular matrix molecules. EC
from a number of different vascular beds have been
shown to synthesise bFGF. Its expression is induced
by exogenous stimulation as well as autocrine control
after injury or mechanical release from growth arrest.
Exogenous bFGF stimulates transcription of its own
gene, acting through a positive feedback loop.
Previous studies in a variety of animal species have
repeatedly demonstrated that extensive endothelial
denudation of the arterial wall by itself may lead
to IH, and supported the notion that certain functions
of endothelial cells EC such as regulation ofl rights reserved.
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molecules were instrumental to the prevention of IH.7
Therefore, novel concepts have been developed to
accelerate re-endothelialisation following balloon-
induced arterial injury.8,9 Application of EC mitogens,
such as bFGF to a freshly injured arterial segment
exerted favourable resparatory effects.10 bFGF beside
VEGF (Vascular Endothelial Growth Factor) brought
about an increased extent of EC outgrowth onto
denuded surfaces and induced a significantly greater
degree of re-endothelialisation.
Photodynamic therapy (PDT) is a technique which
utilizes light activation of otherwise biologically
inert dyes (photosensitisers) to generate free radical
moieties. These radicals, by exerting cytotoxic and
matrix modulating effects, effectively inhibited experi-
mental IH.11±14 Despite prolonged inhibition of cel-
lular repopulation of the media in PDT-treated
arteries, re-endothelialisation of the luminal surface
appeared not to be compromised.
Since the role of matrix-resident bFGF for the prolif-
eration and migration of SMC and EC on PDT-treated
extracellular matrix has been previously established in
the cell culture model of the present study,15 bFGF
expression in EC on PDT-treated matrix was used
to explain accelerated re-endothelialisation of EC
after PDT in vivo. Therefore, the present study was
designed to systematically examine the effect of PDT
on post-injury re-endothelialisation in vivo, and eluci-
date a possible role of altered bFGF-mRNA expression
in EC in vitro.
Materials and Methods
Animal studies
A total of 98 male Sprague Dawley rats (Charles River,
Sulzbach, Germany) weighing 250±350 g, were used in
the study. The animals were anaesthetised with intra-
peritoneal Ketamine (75 mg/kg), Xylazine (5 mg/kg),
and Atropine (40 mg/kg). A midline neck incision was
performed and the left carotid artery exposed. After
clamping the common carotid and the internal carotid
artery, a 2 F Fogarty embolectomy catheter (Baxter
Healthcare, Irvine, CA, U.S.A.) was introduced into
the external carotid artery and forwarded to the
proximal clip. The common carotid artery was sub-
sequently mechanically injured by inflating the
balloon with 0.3 ml air and gently passing and rotating
the catheter three times within the clamped area
of the distal common carotid artery. The position of
the proximal clamp which represented one end ofthe treatment field was marked with a periadventitial
10-0 Nylon Suture (Ethicon, Norderstedt, Germany),
the external carotid artery was ligated with a Prolene
7-0 Suture (Ethicon) and flow to the internal carotid
artery was restored. The carotid bifurcation marked
the corresponding distal end of the treatment field.
Photodynamic therapy
Immediately after the clips were removed from
the carotid artery, and 20 min before the irradiation,
a superficial branch of the left femoral vein was
exposed and the animals received an intravenous
injection of either 1 mg/kg isotonic solution of the
photosensitising dye chloroaluminum sulfonated
phthalocyanine (CASPc; Novartis, Basel, Switzerland)
in phosphate-buffered saline (PDT-Group), or an
equivalent volume of physiologic saline solution (C).
The 1.5 cm distal segment of the common carotid
artery was mounted on a right-angled reflective mir-
ror to provide adequate irradiation to the opposite
vascular wall. Subsequently, a black light impervious
cotton cloth and aluminium foil were placed around
the neck wound to prevent the surrounding tissue
of being directly irradiated. The treatment field was
submerged in saline solution, and 675 nm light at an
irradiance of 100 mW/cm2 and a fluence 100 J/cm2
was delivered by a diode laser system (AOC-LM
500±675, Applied Optronics Corp., South Plainfield,
NJ, U.S.A.) thus avoiding thermal effects.16 The laser
output was coupled to a 400 mm-diameter optical fibre,
and a focal length lens was used to magnify the output
end of the optical fibre to obtain a uniform 2 cm spot.
At the end of the irradiation, wounds were closed by
standard surgical technique.
All procedures were approved by an independent
institutional animal care committee and performed
with permission of the State of Nordrhein Westfalen,
RegierungspraÈsidium KoÈln, according to section 8
of the German Law for the Protection of Animals.
It conforms with the Guide for the Care and Use
of Laboratory Animals (NIH Publication No. 85-23,
revised 1996).
Experimental groups
The animals were assigned to four different experi-
mental groups which were examined immediately
after PDT and at days 1, 3, 5, 14 and 30. Group PDT
received the above mentioned treatment. Controls
included animals which received CASPc intravenous-
ly, without irradiation (DO), intravenous injection of
saline prior to irradiation (LO), and intravenous saline
injection only (C). At 30 days, only animals of groups
PDT and C were investigated.Eur J Vasc Endovasc Surg Vol 24, August 2002
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Under anaesthesia, the femoral vein was exposed
and 0.5 ml of 0.5% Evans Blue (Sigma Chemicals,
Deisenhofen, Germany) in saline were intravenously
injected. Evans Blue binds to albumin and sub-
sequently to collagen which is exposed at places of
disturbed endothelial integrity. Non-endothelialised
surfaces stain blue, whereas endothelialised segments
retain their white colour. Thirty minutes following
injection of the dye, the neck wound was re-opened
and the carotid artery carefully dissected. After eutha-
nasia, a polyethylene tube (14G) was inserted into the
thoracic aorta and flushed with saline for 5 min. The
carotid artery was subsequently removed, longitudi-
nally opened, a ruler placed right beside the artery,
and photos were taken with a digital camera (Minolta,
Langenhagen, Germany).
Morphometric analysis
The pictures were loaded into a personal computer
and planimetric measurements were performed with
a commercially available software (Scion image; Scion
Corp., Frederick, Maryland, U.S.A.). The entire treat-
ment area as well as the blue, de-endothelialised area
were measured, and the percent re-endothelialised
area calculated accordingly. The measurements were
performed for each specimen in triplicate by an indi-
vidual who was blinded for the identity of the speci-
mens. The mean of three measurements was used for
statistical analysis.
Confocal CD-31 immunohistochemistry
CD-31 (PECAM-1) immunohistochemistry was per-
formed to verify the identity of the cells repopulating
the luminal surface of the formerly de-endothelialised
areas. Platelet endothelial cell adhesion molecule-1
(PECAM-1) is a major constituent of the endothelial
cell intercellular junction, and not present on fibro-
blasts, epithelium, muscle, or other nonvascular cells
than circulating platelets, neutrophils, and selected
T-cell subsets.17 It is therefore used to identify
vascular endothelial cells.
Serial cross sections were examined from three
(proximal, mid, distal) segments of the treatment
field. At 3, 5 and 14 days, a separate subset of C
(n 3) and PDT (n 3) arteries were flushed with
saline, and perfusion-fixed in situ with 10% buffered
formalin. Four-micrometer sections were depara-
finised with xylene and rehydrated with graded
methanol. EC were detected using a monoclonal
mouse anti-rat CD-31 fluorescein isothiocyanate-
conjugated antibody (Serotec, Raleigh, NC, U.S.A.)
used at a dilution of 1 : 10 in PBS and incubated for
1 h at 37 C in a humidified chamber. Nuclei wereEur J Vasc Endovasc Surg Vol 24, August 2002stained with propidium iodide at 0.33 m/ml (Oncor,
Purchase, NY, U.S.A.). The localisation of immuno-
positive cells was determined using a confocal
microscope (Bio-Rad MRC-1024/2P multiphoton
microscope, Bio-Rad, Hercules, CA, U.S.A.). Digital
images were captured using an excitation of 494 nm
and 488 nm and emission at 518 nm and 525±550 nm
for fluorescein isothiocyanate and propidium iodide,
respectively. The contralateral, untreated common
carotid artery served as positive control.
In vitro studies
Cell culture
Primary bovine aortic EC cultures were established
from aortas of four freshly slaughtered calves. The EC
were obtained by scraping the intimal aortic surface
and dispersion in 0.1% collagenase I (290 U/mg, in
Hanks' balanced salt solution; Sigma, Deisenhofen,
Germany). The EC identity was confirmed by the
polygonal, monolayer shape seen on phase-contrast
microscopy and by uptake of Di-I-Ac-LDL (Paesel
and Lorie, Hanau, Germany). Cells were kept at 37C
in the presence of 5% CO2 and fed every 48 h
with complete Dulbecco's Modified Eagles Media
(DMEM) supplemented with 10% calf serum,
0.6 mol/L L-glutamine, 100 U/ml penicillin and
100 mg/ml streptomycin (Biochrom, Berlin, Germany).
EC were passed at a ratio of 1 : 5 using 0.05% trypsin/
0.125% ethylenediamine tetra acetic acid upon reach-
ing confluence and used during passages 2 through 5.
Preparation of ECM
EC-derived ECM was prepared as previously
described.15 In brief, the cells were seeded at a density
of 2 105 on 6-well plates, maintained at confluence
for 7±8 days and removed with 0.5% Triton X-100
(Sigma, Deisenhofen, Germany) and 20 mmol/L
NH4OH in phosphate-buffered saline (PBS) for 30 min.
After being rinsed with PBS, the ECM with intact,
associated growth factors12,14,18 was covered with
PBS and stored at 4 C until used for experiments
within 24 h.
Photodynamic therapy
The ECM was covered for 2 h with l.5 ml of the photo-
sensitising dye chloroaluminium sulfonated phthalo-
cyanine (CASPc; Ciba-Geigy, Basel, Switzerland)
diluted in PBS (5 mg/ml). Visible light (l 675 nm,
100 mW/cm2; fluence 100 J/cm2) was delivered by
a diode laser (AOC-LM 500±675, Applied Optronics
Corp., South Plainfield, NJ, U.S.A.). Controls included
plates without ECM (PL) and untreated ECM (C).
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CASPc, ECM was exposed to light irradiation only
(LO) or the ECM was incubated for 2 h with CASPc
solution in the absence of light. In all experiments,
ambient light exposure of the preparations was kept
to a minimum.
Proliferation assay
EC were plated at a density of 2 105 cells per well.
After 24, 48 and 72 h incubation with DMEM contain-
ing 5% fetal calf serum (Biochrom, Hanau, Germany),
the cells were washed 3 times with PBS and 1.5 ml
0.05% trypsin/0.125% ethylenediamine tetra acetic
acid was added for at least 10 min. Subsequently, the
cells were vigorously washed and quantified by
means of fluorescence-labelled cell counting device
(FACS; CCA, Partec, Munster, Germany) at a wave-
length of 435 nm according to the manufacturer's
protocol. The resulting data is expressed as percent
cell count on untreated ECM (C).
Quantitative bFGF mRNA expression
To ensure that cells or ECM was not subjected to
serum constituents that might elicit mRNA expres-
sion, EC were incubated for 24 h with DMEM contain-
ing 0.5% calf serum (serum-poor medium) and seeded
at a density of 5 105 cells per well on the ECM. After
incubation for 12, 24, and 48 h, the medium was
removed and the cell layer was washed with 1 ml
PBS. mRNA was extracted from EC with a mRNA
Isolation Kit (Roche Molecular Biochemicals,
Mannheim, Germany) according to the manufacturers
protocol.
In order to find optimal mRNA concentrations for
the reverse transcription (RT), mRNA eluate was seri-
ally diluted (in 0.5 ml steps) with 0.1% diethyl pyrocar-
bonate treated water. RT was performed using the
First-Strand cDNA Synthesis Kit (Phamacia, Freiburg,
Germany) with pd(N)6 primer according to the man-
ufacturers recommendations. After RT, the samples
were heated at 95C for 5 min to denature active
enzymes, kept on ice and stored at ÿ20 C until the
polymerase chain reaction (PCR) was initiated.
PCR amplification was performed with the Light-
Cycler-DNA Master SYBR Green I and the Light-
Cycler System (both Roche Molecular Biochemicals,
Mannheim, Germany) in a standard PCR reaction.
PCR conditions were optimised by varying the
annealing time and temperature as well as MgCl2-,
Primer- and template-concentrations. For standardi-
sation, each bFGF quantitative RT-PCR experiment
was simultaneously carried out by a quantitative
RT-PCR for b-Actin used as an external standard.A PCR master-mixture was prepared containing
all reagents for either bFGF or b-Actin. For every
b-Actin-PCR with a final volume of 20 ml, 1 mM
(0.8 ml) MgCl2, 2 ml LightCycler-DNA Master SYBR
Green I, 1 ml (each 5 pmol) b-Actinprimer19 (commer-
cially synthesised; Eurogentec, Seraing, Belgium)
(back-primer (50-CAA-CTG-GGA-CGA-CAT-GGA-
GAA-GAT-CTG-GCA-30); for-primer (50-GAG-GAT-
CTT-CAT-GAG-GTA-GTC-TGT-CAG-GTC-30)) and
14.2 ml sterile water was used. For every bFGF-PCR
with a final volume of 20 ml 1 mM (0.8 ml) MgCl2, 2 ml
LightCycler-DNA Master SYBR Green I, 2 ml (each
10 pmol) bFGF-primer20 (commercially synthesised;
Eurogentec, Seraing, Belgium) [back-primer (50-GGC-
TTC-TTC-CTG-CGC-ATC-CA-30); for-primer (50-GCT-
CTT-AGC-AGA-CAT-TGG-AAG-A-30) (position
215±56821 accession-number M13440) and 13.2 ml
sterile water was used. The reaction mixture was
initially incubated for 5 min at 95 C to denature the
DNA. Amplification was performed for 50 cycles of
denaturation (95 C, 1 s, ramp rate 20 C/s), annealing
(58 C 10 s, ramp rate 20 C/s), and extension (72 C,
20 s, ramp rate 2 C/s). Fluorescence was acquired at
the end of each annealing phase.
For quantitative analysis of bFGF mRNA, the
results obtained with the LightCycler instrument
were compared by the LightCycler software with
a standard curve of b-Actin, which was a serially
diluted reamplification product. To equalise differen-
tiation of total mRNA amount, each bFGF result
was divided by its b-Actin value. To verify that the
products were specific for bFGF and b-Actin, a
sequencing procedure using the Big-Dye Terminator
Sequencer Kit and ABI-PRISM 377 DNA Sequencer
(both Perkin Elmer Weiterstadt, Germany) was
performed.
The LightCyclerTM software automatically identi-
fied the exponential phase of the reaction by cycle-
to-cycle monitoring. Thus, a cycle optimation was not
necessary with this system. As the LightCyclerTM
performed rapid thermal cycling, a complete PCR
run of 50 cycles was carried out within approximately
30 min. The exponential phases developed after 15±30
cycles depending on the primer (b-actin or bFGF) and
the isolation of the EC (12, 24, 48 h).
Statistical analysis
For comparison of the in vivo data a Mann±Whitney
U-test was utilised. The in vitro data of the 5 different
experimental groups was performed using a one-way
ANOVA and Tukey's post hoc Spjotvoll-Stoline test
for multiple comparisons. Differences were consid-
ered statistically significant at p5 0.05.Eur J Vasc Endovasc Surg Vol 24, August 2002
Table 1. Re-endothelialised luminal surface area in percent of
the total denuded surface area. DO Drug Only, following
balloon-injury animals received 1 mg/kg of the photosensitiser
CASPc without subsequent irradiation; LOLight Only, animals
were balloon-injured and received saline prior to external beam
laser irradiation. A total of 23 DO animals and 15 LO animals were
analysed. MeanSD.
% Acute Day 1 Day 3 Day 5 Day 14
DO 0 0 0 0 4.3 2 8.0 6.5 71 4.9
n 3 n 5 n 3 n 6 n 6
LO 0 0 0.7 1 3.5 0.7 13.0 4.4 61.0 25.5
n 3 n 3 n 3 n 3 n 3
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Animal studies
All animals appeared healthy, without evidence of
weight loss during the study. Rats subjected to
CASPc developed no signs of systemic phototoxicity.
At harvest one PDT and one C animal of the 3-day
group, one PDT and two C animals of the 5-day group,
and 1 PDT and two C animals of the 30-day group
were found to be occluded. In all other vessels no sign
of occlusion, dilation, or aneurysm formation were
detected.
Planimetric measurements revealed that the mean
denuded treatment area was 23 6 mm2 in PDT
(n 27) vs 22 3 mm2 in C (n 27) (U-test p 0.37).
Immediately after the treatment, the luminal surfaces
of all arteries in groups PDT, C, DO and LO were
entirely blue and not re-endothelialised. At day 1,
beginning from the edges of the treatment field,
re-endothelialisation was appreciated in some PDT
specimens (1.6 1.7%; n 6; KO 0 0.0%; n 6;
U-test p 0.18) (Fig. 1). At three days, PDT-treated
arteries demonstrated 9.3 0.5% (n 4) of the
formerly denuded luminal area to be white
(re-endothelialised), whereas C was slightly, but sig-
nificantly less re-endothelialised (5.6 2.2%; n 4;
U-test p 0.02). At five days (PDT 19.8 1.7%; n 4
vs C 11.5 2.7%; n 4; U-test p 0.03) and 14 days
(PDT 89.7 4.0%; n 5 vs C 72.8 6.8%; n 5;
U-test p 0.02) the differences in both groups were
found to be more pronounced with an increased
re-endothelialised surface area of PDT-treated arteries.*
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Fig. 1. Re-endothelialised luminal surface area in percent of the
total denuded surface area. Filled circles (PDT) denote balloon-
injured rat common carotid arteries which were PDT treated im-
mediately after balloon-injury. Open circles (C) represent control
arteries with balloon-injury only; Mean SD; n 4±6 per group
and time point,  statistically significant difference (Mann±
Whitney U-test p5 0.05).
Eur J Vasc Endovasc Surg Vol 24, August 2002At 30 days a trend, but not a significant difference
between PDT (93.3 2%; n 4) vs C (88.8 3%;
n 4; U-test p 0.06) was noted (Fig. 1). As internal
controls for the PDT effect, animals subjected only
to the photosensitising drug or to light only were
examined 1, 3, 5, and 14 days following the treatment.
At no time point significant differences to C were
observed (Table 1).
Immunofluorescence staining for EC (CD-31)
revealed no detectable cells in the intima andFig. 2. Confocal immuno-fluorescence microscopy with anti-CD-31
(PECAM-1) for identification of endothelial cells on the luminal
surface of rat common carotid arteries (cross sections). Nuclear
counterstain with propidium iodide (red nuclear staining). (a) nor-
mal rat common carotid artery. Note: a layer of flat cells with green
(CD-31 positive) granules around the nucleus on the luminal surface
of the artery (endothelial cells). Green auto-fluorescence of the
adventitia. The cells in the media and adventitia do not contain
green granules. (b) PDT-treated artery 1 day after PDT. Note: no
cells at the luminal surface and the media. Auto-fluorescence of the
acellular matrix in the media. Rare nuclei in the adventitia. (c) PDT-
treated artery 14 days after PDT. Note: flat CD-31-immuno-positive
cells at the luminal surface. The media remains cell-free. Cellular
repopulation of the adventitia with CD-31-negative cells. White box
represents higher magnification (100) of a CD-31-positive endo-
thelial cell. Original magnification of the other pictures 40.
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layer of flat immunopositive cells on the luminal
surface of the artery was present at 14 days after
PDT (Fig. 2).*
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Fig. 3. Proliferation of endothelial cells (EC) plated on differently
treated EC-derived extracellular matrix (ECM) at 24, 48 and 72 h
Cnormal EC-derived matrix; PDTPDT-treated ECM; PLno
ECM (Plate only); DOECM incubated with CASPc for 2 h;
LOECM irradiated with red light at 100 J/cm2; Mean SD; statistically significant difference vs C, ANOVA p5 0.05.In vitro studies
EC proliferation was determined at 24, 48 and 72 h.
The numbers of EC which were plated on PDT-treated
ECM (n 12) was increased to 111 7.6% of C
(100 4.4%; n 12) at 24 h and remained high for up
to 72 h (ANOVA p 0.0004) (Fig. 3). EC on cell culture
plastic (PL) as well demonstrated increased prolifera-
tion vs C (ANOVA p 0.0005), whereas DO and LO
remained nearly unchanged (Fig. 3).
To examine whether increased proliferation of EC
was caused by autocrine stimulation through
increased bFGF levels, bFGF-mRNA expression in
EC was determined at 12, 24, and 48 h (Fig. 4). At
12 h, no detectable differences between the groups
were measured. At 24 h, however, bFGF-mRNA
expression of EC on PDT-treated ECM was signif-
icantly increased as compared to C (ANOVA
p 0.007). EC on PL as well displayed increased levels
of bFGF-mRNA at 24 h (ANOVA p 0.0003). Never-
theless, at 48 h no differences between the groups
were found (Fig. 4).
Discussion
As a continuation of previous work from this group,
the primary goal of the present study was to verify
accelerated re-endothelialisation following balloon-
injury and PDT and suggest a possible mechanism
for this observation. The rat common carotid artery
balloon-injury model is commonly used to study post-
injury IH. Although this model does not give an exactHours
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Fig. 4. Basic fibroblast growth factor mRNA expression in endothe-
lial cells (EC) plated on normal EC-derived extracellular matrix
(C; open circles), PDT-treated ECM (PDT; filled circles), and on
cell culture plate plastic only (PL; dotted squares) at 12, 24 and
48 h. The values represent percent of C. Mean SD; ANOVA p5 0.05 vs C at the same time point; { p5 0.05 vs PDT at the
same time point.
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172 F. Adili et al.representation of the complex human situation, it
is commonly regarded sufficient to elucidate key
mechanisms of post-injury cell proliferation in the
vascular wall and develop therapeutic modalities to
inhibit IH. Using balloon-injury and a standardised
treatment protocol, it has been repeatedly demon-
strated that PDT prevented IH development.22±24 In
a number of subsequent studies, we were able to
reproduce this result using the same PDT technique
and to demonstrate significant inhibition of IH for
up to 16 weeks.11,25,26 Therefore, systematic morpho-
metric measurements to quantify the degree of IH
development were omitted in the present study. How-
ever, by gross examination the degree of IH develop-
ment appeared significantly lower in the PDT group
(data not shown).
For technical reasons, endoluminal drug delivery
and endoluminal irradiation, which are regarded to
be more favourable for the clinical use of PDT, could
not be performed in the rat common carotid artery
model. However, occasional IH right opposite to the
external laser light path was observed with external
irradiation.23 According to the law of LAMBERT-
BEER, the penetration depth of light depends on its
wavelength. Despite the use of light at 675 nm, which
has good penetration in tissue, light energy is reduced
by 60% after crossing a 0.8 mm diameter artery. This
probably results from light absorption and scattering
by the photosensitiser in the serum and red blood
cells. The decrease in light energy across the vessel
accounts for non-homogenous light dosimetry and
occasional intimal hyperplasia at the posterior aspects
of the arterial wall which lead to the definition of the
so called `` half moon effect''.23 To address this issue,
a reflective mirror is placed beneath the artery. In
subsequent studies this problem has not occurred
with external beam irradiation, and sufficient light
was delivered through the entire arterial wall.11,25
The rationale to investigate accelerated reendo-
thelialisation in vivo originated from the in vitro
observation of increased proliferation and migration
of EC on isolated PDT-treated bovine EC-derived
extracellular matrix.15 The respective methodology
and PDT dosimetry were established in previous
experiments.14,15,27 Cultured bovine vascular ECs
produce an extracellular matrix that is similar in
organisation and macromolecular composition to the
naturally occurring subendothelium.28 This matrix
does not only function as an inert structural support,
but rather regulates attachment, proliferation,
migration, and differentiation of cells.29 For the
in vitro study only the isolated extracellular matrix
was incubated with the photosensitiser. The number
of EC was determined after 24, 48 and 72 h. CellEur J Vasc Endovasc Surg Vol 24, August 2002counting at 0 h which describes the plating efficiency
was omitted in the present study since previous data
using an identical experimental set-up and protocol
indicated that the attachment of EC in the differently
treated matrices (C, PDT, DT, LO) was identical.15
The approach implied by this study, utilising PDT
not only as a method to inhibit the functions of SMC,
but also to promote proliferation, migration, viability
and other biological functions of EC, represents an
attempt to prevent the development of IH and to
induce favourable remodeling. One of the major limi-
tations to strategies which aim at anti-proliferation,
anti-migration, and anti-inflammation to inhibit pro-
liferating SMCs and myofibroblasts may be founded
in the accompanying belated re-endothelialisation.1
A number of studies have defined the role of
endothelial growth factors in modulating the
re-endothelialisation process. In fact, the capability of
certain cytokines to serve as mitogens for ECs in vitro
suggests that such growth stimulatory molecules
might be exploited to accelerate re-endothelialisation
subsequent to balloon injury or plaque rupture.8 In the
case of bFGF, systemic administration of this growth
factor induced a highly significant increase in the
replication rate of EC at the leading edge of the re-
growth process.10 Since bFGF is also a growth factor
for SMC, its final effect on IH may be the consequence
of a balance between stimulatory and inhibitory
mechanisms of SMC growth.1
PDT modulated this balance in a unique way:
following PDT of balloon-injured rat carotid arteries,
cellular repopulation of the media was significantly
inhibited, while re-endothelialisation appeared to be
un-compromised.11 Moreover, EC-re-growth on the
luminal surface was slightly, but significantly acceler-
ated compared to control arteries, as evidenced by the
present study. The rapid regeneration of EC appears
to contribute to the suppression of IH: animals in a
PDT-treated group demonstrated less intimal thicken-
ing than those in the control group at 2, 4, 8, and 16
weeks after injury.11 An inverse relationship between
re-endothelialisation and neointimal SMC prolifer-
ation was graphically demonstrated in a previous
study using direct application of VEGF to the
denuded surface of the rat carotid artery.8 More than
96% of PCNA-immunopositive cells in the neo-intima,
indicating cells in the S-phase of their replication
cycle, were observed both, in the VEGF and the con-
trol group at all neointimal sites devoid of endothe-
lium. IH thus developed in association with delayed
re-endothelialisation. Conversely, the observations
from that study suggested, that if re-endothelialisation
could be accelerated, then associated neointimal thick-
ening would be correspondingly reduced. Others
Accelerated Re-endothelialisation Following Injury 173have supported the notion that certain functions of the
EC ± including barrier regulation of permeability,
thrombogenicity and leukocyte adherence, as well
as production of growth-inhibitory molecules ± are
critical to the prevention of luminal narrowing by IH.7
The mechanism by which PDT induced accelerated
re-endothelialisation and inhibited neointimal thick-
ening was very different from the VEGF approach.
First, the effector cells of IH in the vascular wall and
periadventitial tissues are entirely eliminated by gross
induction of apoptosis,30 without inflammatory
response and destabilisation of the structural integrity
of the artery.31 Second, cellular repopulation of
the media is probably inhibited by direct alteration
of structural matrix proteins in the ECM such as
collagen.32 Homotype cross-links of collagen and
heterotype cross-links between collagen and serum
albumin rendered the media impervious for the
migration of SMC by inhibition of protease diges-
tion,32 and depletion of matrix-associated growth
factors of SMC.12,15 Therefore, the mere physical
remoteness of EC and SMC probably prevented them
from directly interacting with each other.
Third, under physiologic conditions, EC do not
release bFGF.33 However, following injury bFGF
is liberated and subsequently stimulates SMC in a
paracrine fashion.34 In a state of increased migratory
and proliferative activity such as accelerated
re-endothelialisation, increased intracellular bFGF
protein levels and autocrine stimulation of EC is
noted.4,35±38 When plated on PDT-pre-treated ECM
which was used for the in vitro part of the present
study, EC exhibited increased intracellular bFGF-
mRNA expression at 24 h and increased proliferation
for up to 72 h. In this model, PDT of the ECM inactiv-
ated bFGF without compromising the functional
integrity of the matrix-resident low-affinity bFGF
receptors (heparan sulphates).12 Therefore, exogenous
bFGF-replenishment of PDT-treated ECM resulted in
restoration of cell proliferation to levels comparable
with normal, untreated ECM.12 The biological func-
tions of bFGF are mediated by their interaction with
both high- and low-affinity plasma membrane recep-
tors.39 The low affinity receptors consist of heparan
sulphate proteoglycans at the cell surface and the
surrounding ECM and are thought to provide a mech-
anism both to concentrate ligand and to present bFGF
dimers to high-affinity tyrosine kinase receptors
which mediate the mitogenic effect.39 In vitro studies
with 3T3 fibroblasts indicated that the four isoforms of
bFGF (three high molecular weight isoforms and one
low molecular weight 18 kDa cytosolic isoform) can
independently activate a biological response by
nuclear localisation of low molecular weight bFGFwhose amino acid sequence is common to all
forms.35 This nuclear localisation is sufficient for
the modulation of low serum growth, indicating that
this sequence may represent the actual biological
messenger of bFGF in both the intracrine and auto-
crine pathways.35 The up-regulation of bFGF-mRNA
in EC plated on PDT-treated ECM provides an add-
itional mechanism by which accelerated re-endothe-
lialisation may have been induced. This up-regulation
was probably induced by the absence of matrix-asso-
ciated bFGF following the PDT-treatment. A combin-
ation of absent bFGF on one hand and absent ECM on
the other hand, in the PL group, may have also been
the stimulus for increased bFGF-mRNA expression
and proliferation of EC.
The in vivo efficiency of PDT-inactivation of bFGF
in the intima, media, and adventitia of rat carotid
arteries has been previously demonstrated by means
of immunohistochemistry.12,40,41
Fourth, in the present model, ECM deposited by EC
on tissue culture plates contains TGF-b1, a potent
inhibitor of EC growth, which is inactivated by
PDT.13 PDT of fibronectin-bound TGF-b1 stimulated
EC mitogenesis as compared to untreated control.
This observation demonstrated that increased EC pro-
liferation on PDT-treated ECM is, at least in part, also
mediated by inactivation of TGF-b1, which provides
another mechanism by which PDT of the vascular wall
could potentiate endothelial re-growth.13
The functional relevance of increased bFGF-mRNA
and protein expression in EC has been previously
studied.5,6,10,42 Increased bFGF expression of EC
resulted in increased proliferation and migration.
Addition of neutralising anti-bFGF antibodies to
resting as well as activated EC in vitro led to down-
regulation of MCP-1 and inhibited migration of EC.43
Regenerating EC expressed elevated levels of
endogenous bFGF after aortic denudation injury, sug-
gesting that similar autocrine and/or local paracrine
mechanisms of bFGF-mediated MCP-1 induction
acted on endothelial MCP-1 expression in vivo and
in vitro. The regulation of MCP-1 expression through
EC-derived bFGF supports the concept that bFGF acts
as a major autocrine regulator of different functions of
activated EC.43 Though the present study did not
demonstrate a causal relationship between the prefer-
ential up-regulation of bFGF in vitro and an acceler-
ated re-endothelialisation after PDT treatment in vivo,
from previous data it appears likely that bFGF-mRNA
expression and increased proliferation of EC act in
synergy to result in faster re-endothelialisation and
inhibition of IH.
In conclusion, the present data suggest that post-
injury-PDT accelerates re-endothelialisation. AlthoughEur J Vasc Endovasc Surg Vol 24, August 2002
174 F. Adili et al.expression of bFGF-mRNA was turned up in vitro, this
mechanism may not solely be responsible for a
constant stimulation of EC proliferation following
PDT. However, PDT-mediated acceleration of re-
endothelialisation may represent a contributory mech-
anism and favourable side effect of this innovative
strategy. Subsequent animal studies and clinical trials
will be required to substantiate this hypothesis and
introduce this technique as an effective and efficient
method to pre-empt restenosis.
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